iSOFT Signs Sixth LORENZO Site in Germany

iSOFT Group LimitediSOFT Group Limited (ASX: ISF) - Australia's largest listed health information technology company today announced that Christophorus-Kliniken will become the sixth early adopter of iSOFT’s LORENZO next-generation solution in Germany as part of an agreement to upgrade hospital information systems (HIS) at its three hospitals in the Coesfeld district of North Rhine-Westphalia.

The five-year deal potentially is worth as much as €1.43 million (A$2.5 million). The initial two phases, which include the first LORENZO components and an upgrade of iSOFT's ClinicCentre HIS solution, are valued at €675,000 (A$1.2 million) in license fees and services plus €257,000 (A$447,000) in support and maintenance services over five years. An optional third phase, which includes additional LORENZO functionality, is worth a potential €500,000 (A$870,000).

"This is further evidence that our new LORENZO technology is gaining traction with our existing client base in Europe," said Gary Cohen, iSOFT's Executive Chairman & CEO. "It's part of our broader strategy for LORENZO outside of the UK's National Programme for Information Technology."

The first LORENZO elements and iSOFT's Collaboration Suite (iCS) will provide a new electronic patient record (EPR) for GP's to access hospital patient records using standard web browsers. iCS allows the secure exchange of patient information between care providers to improve collaboration between teams.

Christophorus-Kliniken follows Klinikum Saarbrücken, which recently became iSOFT's fifth LORENZO early adopter in Germany. The three Christophorus-Kliniken hospitals covered by the new contract are Coesfeld's St Vincenz Hospital, Franz Hospital at Dülmen and St Gerburgis Hospital at Nottuln, which provide a total of 620 beds and employ 1,500 staff.

Christophorus-Kliniken is an existing client for iSOFT's ClinicCentre and its LabCentre laboratory information system and BusinessCentre finance, administration and management solution.

Other LORENZO early adopters in Germany are Aachen, Leipzig, Krankenhaus Buchholz and Winsen, and Klinikum Saarbrücken.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in 38 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The Group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,600 specialists in 16 locations worldwide, including more than 2,300 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...